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The N-acylethanolamines (NAEs), oleoylethanolamide (OEA) and palmithylethanolamide
(PEA) are known to be endogenous ligands of PPARα receptors, and their
presence requires the activation of a specific phospholipase D (NAPE-PLD) associated
with intracellular Ca2+ fluxes. Thus, the identification of a specific population of
NAPE-PLD/PPARα-containing neurons that express selective Ca2+-binding proteins
(CaBPs) may provide a neuroanatomical basis to better understand the PPARα system in
the brain. For this purpose, we used double-label immunofluorescence and confocal laser
scanning microscopy for the characterization of the co-existence of NAPE-PLD/PPARα
and the CaBPs calbindin D28k, calretinin and parvalbumin in the rat hippocampus. PPARα
expression was specifically localized in the cell nucleus and, occasionally, in the cytoplasm
of the principal cells (dentate granular and CA pyramidal cells) and some non-principal
cells of the hippocampus. PPARα was expressed in the calbindin-containing cells of
the granular cell layer of the dentate gyrus (DG) and the SP of CA1. These principal
PPARα+/calbindin+ cells were closely surrounded by NAPE-PLD+ fiber varicosities.
No pyramidal PPARα+/calbindin+ cells were detected in CA3. Most cells containing
parvalbumin expressed both NAPE-PLD and PPARα in the principal layers of the DG
and CA1/3. A small number of cells containing PPARα and calretinin was found along
the hippocampus. Scattered NAPE-PLD+/calretinin+ cells were specifically detected
in CA3. NAPE-PLD+ puncta surrounded the calretinin+ cells localized in the principal
cells of the DG and CA1. The identification of the hippocampal subpopulations of
NAPE-PLD/PPARα-containing neurons that express selective CaBPs should be considered
when analyzing the role of NAEs/PPARα-signaling system in the regulation of hippocampal
functions.
Keywords: PPAR alpha, NAPE-PLD, calcium-binding protein, hippocampus, rat, immunohistochemistry, confocal
microscopy
INTRODUCTION
N-acylethanolamines (NAEs), including oleoylethanolamide
(OEA) and palmithylethanolamide (PEA), exert a variety of bio-
logical activities in the central nervous system (Calignano et al.,
1998; Combs et al., 2001; Inoue et al., 2001; Rodríguez de
Fonseca et al., 2001; Okamoto et al., 2007). NAE biosynthesis
has been proposed to occur on demand via a two-step enzy-
matic process. First, a Ca2+-activated N-acyltransferase transfers
the ns-1 acyl chain of a phospholipid to the amine of phos-
phatidylethanolamine (PE) to generate an N-acyl PE (NAPE) (Di
Marzo et al., 1994). Then, NAPE is converted into an NAE and
phosphatidic acid by phospholipase D (PLD) (Schmid, 2000).
The molecular identity of the Ca2+-activated N-acyltransferase is
currently unknown, while the N-acyl phosphatidylethanolamine
phospholipase D (NAPE-PLD) that is expressed in specific
regions of the brain has been identified (Di Marzo et al., 1996;
Okamoto et al., 2004). The brain tissue of NAPE-PLD knock-
out mice showed a five-fold reduction in the Ca2+-dependent
conversion of NAPEs to NAEs, which affected both endocannabi-
noids, such as anandamide, and the PPARα receptor ligands PEA
and OEA (Leung et al., 2006). Accordingly, NAPE-PLD activ-
ity is highly associated with intracellular Ca2+ stores in several
types of hippocampal excitatory axon terminals (Nyilas et al.,
2008).
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The PPARα receptor, which shows specific patterns of
localization in the brain (Braissant et al., 1996; Cullingford
et al., 1998; Moreno et al., 2004), appears to mediate the sig-
naling effects of monounsaturated NAEs. Its activation results
in the up-regulation of target genes involved in learning,
memory, aging, neurodegeneration and inflammation (Combs
et al., 2001; Inoue et al., 2001). Several reports showed that
PPARα activation resulted in prevention of cognitive impair-
ment (Greene-Schloesser et al., 2014) and neuroprotection after
neuronal damage in animal models of Parkinson’s diseases or
after excitotoxic lesions and ischemia (Lombardi et al., 2007;
Sun et al., 2007; Bisogno and Di Marzo, 2008; Galán-Rodríguez
et al., 2009; Garg et al., 2011; Koch et al., 2011; Esposito et al.,
2012; Zhou et al., 2012). Moreover, PPARα activation induces
biological mechanisms that require the participation of intra-
cellular Ca2+ (Di Marzo et al., 1994; Khasabova et al., 2012),
such as the induction of peroxisomal proliferation, attenuation
of neurotoxicity, decreases in intraneuronal ROS production and
prevention of the calcium influx induced by H2O2 (Santos et al.,
2005; Galán-Rodríguez et al., 2009; Esposito et al., 2012; Scuderi
et al., 2012).
Calcium-binding proteins (CaBPs) belonging to the calmod-
ulin superfamily play important roles as intracellular Ca2+ buffers
and sensors in mediating Ca2+-dependent events, such as synap-
tic transmission and axonal transport (Nakamura et al., 1980).
Several CaBPs, including calbindin D28k, calretinin and parval-
bumin, have been found in high concentrations in the brain
(Baimbridge et al., 1982; García-Segura et al., 1984). CaBPs
deficits have been related to relevant neurodegenerative pro-
cesses, such as Alzheimer’s disease, Parkinson’s disease, age-
related cognitive defects, schizophrenia, epilepsy, and some forms
of tumors (Maglóczky et al., 1997; Cates et al., 2006; Nakazawa
et al., 2012; Verret et al., 2012). These CaBPs usually corre-
late with neurotransmitter content, cell morphology, distribu-
tion, and function (Baimbridge et al., 1982; Celio, 1990; Gulyás
et al., 1991) and are used to classify neurons into specific
subpopulations. For instance, hippocampal non-pyramidal cells
containing calretinin and parvalbumin are usually GABAergic
neurons (Kosaka et al., 1987; Miettinen et al., 1992; Wouterlood
et al., 2001). Moreover, it was demonstrated that parvalbumin-
positive CA1 interneurons are required for spatial working
but not for reference memory (Murray et al., 2011), whereas
calbindin-positive granule cells of the dentate gyrus (DG) con-
tribute to verbal memory impairments in temporal lobe epilepsy
(Karádi et al., 2012).
It has been hypothesized that CaBPs buffer the intracellu-
lar Ca2+ levels, resulting in the regulation of NAE production
through the Ca2+-sensitive enzyme NAPE-PLD, and as a con-
sequence, CaBPs can influence PPARα activity. This hypothesis
supports the need for the identification of the cells that co-express
or do not co-express the CaBPs and the NAPE-PLD/PPARα
signaling system. In the present study, we described and system-
atically characterized specific hippocampal PPARα and NAPE-
PLD-containing cells that express the three CaBPs, calbindin
D28k, calretinin, and parvalbumin. For this purpose, we used
double-label immunofluorescence and confocal laser scanning
microscopy.
MATERIALS AND METHODS
ANIMALS
Adult male Wistar rats (n = 5), weighing approximately 250 g
and 10–12 weeks old (Charles River Laboratories, Barcelona,
Spain), were used in this study. Male total-NAPE-PLD-KO mice
andmale total-PPARα-KOmice (n = 2), weighing approximately
25 g and 8 weeks old, were used in this study. The animals were
kept in standard conditions (Servicio de Estabulario, Facultad de
Medicina, Universidad de Málaga) at 20 ± 2◦C room tempera-
ture, 40 ± 5% relative humidity and a photoperiod of 12L:12D;
the rats were given free access to food and water. All experi-
mental animal procedures were performed in compliance with
the European Communities directive 86/609/ECC and Spanish
legislation (BOE 252/34367-91, 2005) regulating animal research.
TISSUE PROCESSING
The animals were anesthetized with sodium pentobarbi-
tal (50mg/kg, i.p.) and transcardially perfused with 0.1M
phosphate-buffered saline (PBS; pH 7.3), followed by 4%
formaldehyde in PBS. The brains were dissected and incubated
in the same fixative solution overnight at 4◦C, then cryoprotected
in 0.1M phosphate-buffered saline pH 7.3 (PBS) containing 30%
sucrose and 0.01% sodium azide (NaN3) for 48 h. Then, the
brains were cut into 30-μm thick transverse sections using a slid-
ingmicrotome. The sections were stored at 4◦C in PBS containing
0.002% (w/v) NaN3 until immunohistochemistry analysis.
IMMUNOHISTOCHEMISTRY
For the analysis of the immunohistochemical expression of
PPARα, NAPE-PLD and the Ca2+-binding proteins (calbindin,
calretinin, and parvalbumin) in the hippocampus, free-floating,
30-μm thick coronal sections from the −3.00 to −4.80mm
Bregma levels were used (Paxinos and Watson, 2007). The sec-
tions were first washed several times with 0.1M PBS (pH 7.3) to
remove the NaN3 and were incubated in H2O containing 50mM
sodium citrate (pH 6) for 30min at 80◦C, followed by several
washes in 0.1M PBS (pH 7.3). Then, the sections were incubated
in a solution of 3% hydrogen peroxide and 10% methanol in
0.1M PBS for 20min at room temperature in the dark to inacti-
vate the endogenous peroxidase, followed by washes in PBS. The
sections were then blocked with 10% donkey or goat serum in
PBS containing 0.1% NaN3 and 0.2% Triton X-100 and incu-
bated with a primary antibody overnight at room temperature
(for details regarding the antibodies used, see Tables 1, 2).
The following day, the sections were washed in PBS and
incubated with a biotinylated secondary antibody diluted 1:500
for 1 h (Table 2). The sections were washed again in PBS
and incubated with a 1:2000 dilution of ExtrAvidin peroxidase
(Sigma, St. Louis, MO) for 1 h. After several washes, immuno-
labeling was revealed by exposure to 0.05% diaminobenzidine
(DAB; Sigma), 0.05% nickel ammonium sulfate and 0.03%
H2O2 in PBS. After several washes in PBS, the sections were
mounted on slides treated with poly-l-lysine solution (Sigma),
air-dried, dehydrated in ethanol, cleared with xylene and cover-
slipped with Eukitt mounting medium (Kindler GmBH & Co,
Freiburg, Germany). Digital high-resolution photomicrographs
of the rodent brains were taken under the same conditions of
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Table 1 | Primary antibodies used.
Antigen Immunogen Manufacturing details Dilution References
PPARα Synthetic Peptide:
M(1)VDTESPICPLSPLEADD (18)C
Fitzgerald
Affinity purified
polyclonal IgG antibody
Developed in rabbit
Code No.: 20R-PR021
Lot. No.: P11120812
1:100 Suardíaz et al., 2007
NAPE-PLD Mouse N-terminal 1-41aa polypeptide
(AB112350):
MDEYEDSQSPAPSYQYPKETLRKR
QNSVQNSGGSVSSRFSR
Frontier Institute
Affinity purified
polyclonal IgG antibody
Developed in guinea pig
Code No. GP-Af720
Lot. No.: Not provided
1:500 Leung et al., 2006
Nyilas et al., 2008
Calbindin Calbindin D28k purified from chicken gut:
MTAETHLQGVEISAAQFFEIWHHYDSDG
NGYMDGKELQNFIQELQQARKKAGLDL
TPEMKAFVDQYGKATDGKIGIVELAQVL
PTEENFLLFFRCQQLKSSEDFMQTWRKY
DSDHSGFIDSEELKSFLKDLLQKANKQIE
DSKLTEYTEIMLRMFDANNDGKLELTEL
ARLLPVQENFLIKFQGVKMCAKEFNKAF
EMYDQDGNGYIDENELDALLKDLCEKN
KKELDINNLATYKKSIMALSDGGKLYRA
ELALILCAEEN
Swant
Monoclonal IgG antibody
Produced in mouse
myeloma cells
Code No.: 300
Lot. No.: 07 (F)
1:500 Celio, 1990
Rüttimann et al., 2004
Suárez et al., 2005
Calretinin Recombinant human calretinin 22k
(epitope within the first 4 EF-hands
domains):
MAGPQQQPPYLHLAELTASQFLEIWKHF
DADGNGYIEGKELENFFQELEKARKGSG
MMSKSDNFGEKMKEFMQKYDKNSDGK
IEMAELAQILPTEENFLLCFRQHVGSSAE
FMEAWRKYDTDRSGYIEANELKGFLSDL
LKKANRPYDEPKLQEYTQTILRMFDLNG
DGKLGLSEMSRLLPVQENFLLKFQGMKL
TSEEFNAIFTFYDKDRSGYIDEHELDALL
KDLYEKNKKEINIQQLTNYRKSVMSLAE
AGKLYRKDLEIVLCSEPPM
Swant
Monoclonal antibody
Developed in mouse
Code No.: 6B3
Lot. No.: 010399
1:500 Zimmermann and
Schwaller, 2002
Rüttimann et al., 2004
Suárez et al., 2006
Parvalbumin Parvalbumin purified from carp muscles:
MAFAGILNDADITAALQGCQAADSFDY
KSFFAKVGLSAKTPDDIKKAFAVIDQDK
SGFIEEDELKLFLQNFSAGARALTDAETK
AFLKAGDSDGDGKIGVDEFAALVKA
Swant
Monoclonal IgG antibody
Produced in mouse
myeloma cells
Code No. 235
Lot. No.: 10–11 (F)
1:500 Celio, 1986
Bouilleret et al., 2000
light and brightness/contrast using an Olympus BX41 micro-
scope equipped with an Olympus DP70 digital camera (Olympus
Europa GmbH, Hamburg, Germany).
DOUBLE IMMUNOFLUORESCENCE
Hippocampal sections were pretreated as described above and
incubated overnight at room temperature with a cocktail of
primary antibodies (Table 1). After washing in 0.1M PBS
(pH 7.3), the sections were incubated for 2 h at room tem-
perature with a cocktail of fluorescent secondary antibodies
(Table 2) for 2 h. In some cases, we used the nuclei marker
4′,6-diamine-2-phenylindole dihydrochloride (DAPI, ref. no.
D9542, SIGMA) to identify the cell nuclei of specific hip-
pocampal cell populations. For epifluorescence analysis, digital
high-resolution microphotographs were taken using an Olympus
BX41 fluorescence microscope equipped with an Olympus DP70
digital camera (Olympus). For a more detailed analysis, the
sections that were doubly labeled were visualized using a con-
focal laser (spectral) scanning microscope (Leica TCS NT; Leica
Microsystems) equipped with a 561 nm DPM laser (argon 30%)
Frontiers in Neuroanatomy www.frontiersin.org March 2014 | Volume 8 | Article 12 | 3
Rivera et al. PPARα and Ca2+-binding proteins in the hippocampus
and a 63 × objective (HCX PL APO CS 63.0×1.40 OIL UV). The
numerical aperture was 1.40. The emission filter settings were
430–483 nm for PMT1 (blue), 504–545 nm for PMT2 (green),
and 570–630 nm for PMT3 (red). The channels of the images were
taken sequentially with a frame average of 3. Depending on the
level of zoom used in each image, the XY voxel size ranged from
240.5 nm (zoom = 1) to 29.4 nm. The pinhole (airy) was 1. The
section thickness (Z) was 772 nm. Thus, we could discriminate
the labeling of those structures whose size was larger than the
image resolution. Settings of light and brightness/contrast were
adjusted by using the Leica LAS AF Lite imaging software.
ANTIBODY SPECIFIC AND CONTROLS
We performed Western blot analyses to demonstrate that the
PPARα, NAPE-PLD, calbindin, calretinin, and parvalbumin anti-
bodies recognized the corresponding antigen in the rat hip-
pocampus. To perform Western blot analysis, we used fresh
tissue from Wistar male rats. The animals were sacrificed using
2,2,2-tribromoethanol (Fluka, Steinheim, Germany), and the hip-
pocampi were immediately isolated, snap frozen in liquid nitro-
gen and stored at −80◦C until use. Protein extracts of the rat
hippocampi were prepared in RIPA buffer (50mM Tris-HCl
pH 7.4, 150mM NaCl, 0.25% NaDOC, 1% Triton-X100, 1mM
EDTA, 10% aprotinin) using a homogenizer. After 2 h of incu-
bation with agitation at 4◦C, the homogenate was centrifuged at
20,800 g for 20min at 4◦C, and the supernatant was collected.
For immunoblot analysis, equivalent amounts of protein
extract (75μg) were separated on 4–20% precast polyacrylamide
Table 2 | Secondary antibodies used.
Antigen Produced Conjugate Manufacturing Dilution
in to details
Anti-rabbit
IgG
Donkey Biotin GE Healthcare
Code No.: RPN1004
Lot. No.: 5356499
1:500
Anti-mouse
IgG
Goat Biotin SIGMA
Code No.: B 7264
Lot. No.: 125K6063
1:500
Anti-guinea
pig IgG
Goat Biotin Vector Laboratories
Code No.: BA-7000
Lot. No.: W0726
1:500
Anti-rabbit
IgG
Donkey Cy3 bis-NHS
ester
Jackson
ImmunoResearch
Code No.: 711-166-152
Lot. No.: 101675
1:300
Anti-mouse
IgG
Goat Fluorescein
Isothiocyanate
(FITC)
SIGMA
Code No.: F2012
Lot. No.: 107K6058
1:300
Anti-guinea
pig IgG
Goat Cy3 bis-NHS
ester
Jackson
ImmunoResearch
Code No.: 106-165-003
Lot. No.: 106592
1:300
gels (Criterion™ TGX™ Precast Gel, Bio-Rad, cat. no. 567-1093),
electroblotted onto nitrocellulose membranes and stained with
Ponceau red to ensure equal loading. The blots were first incu-
bated with a blocking buffer containing 2% bovine serum albu-
min (Merck) in PBS and 0.1% Tween 20 at room temperature
for 1 h. Then, each blotted membrane lane was incubated sep-
arately with the specific PPARα (1:500), NAPE-PLD (1:200),
calbindin D28k (1:500), calretinin (1:1000), or parvalbumin
(1:1000) antibodies. Peroxidase-conjugated goat anti-rabbit, goat
anti-mouse, and goat anti-guinea pig antibodies (dilution 1:2000;
Promega, Madison, WI, USA) were added for 1 h at room tem-
perature. The specific protein bands were visualized using the
enhanced chemiluminescence technique (ECL, Amersham) and
the Auto-Biochemi Imaging System (LTF Labortechnik GmbH,
Wasserburg/Bodensee, Germany). Western blot analysis showed
that each primary antibody detected a protein of the expected
molecular size (Figure 1A).
Because of the described variability of NAPE-PLD distribu-
tion with respect to the different antibodies used (Egertová et al.,
2008; supplementary figures in Suárez et al., 2008; present study),
we carried out additional control experiments to ensure the
FIGURE 1 | (A) Western blot analysis of protein extracts from the rat
hippocampus showing the prominent immunoreactive bands of the
expected molecular masses of 52 kDa for PPARα, 46 kDa for NAPE-PLD,
28 kDa for calbindin, 29 kDa for calretinin, and 10 kDa for parvalbumin. The
positions of the molecular markers are indicated on the left. (B,C)
Comparative immunohistochemical analysis of NAPE-PLD expression in the
hippocampus (DG, CA1, CA3) of the NAPE-PLD wild-type mouse (B) and
the NAPE-PLD knockout male mouse (C). (D,E) Comparative immuno-
histochemical analysis of PPARα expression in the hippocampus (DG, CA1,
CA3) of the PPARα wild-type mouse (D) and the PPARα knockout male
mouse (E). For abbreviations, see Table 3 legend. Scale bars are indicated
in each image.
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specificity of the antibodies. To this end, the hippocampus of a
wild-type mouse was compared with those of NAPE-PLD knock-
out mice (Leung et al., 2006; Nyilas et al., 2008). The specificity
of the PPARα antibody in the brains of the PPARα knock-out
mice was also tested (Suardíaz et al., 2007). The immunohisto-
chemical protocol for NAPE-PLD and PPARα was carried out
as described above (Table 1). We observed that immunostaining
was completely absent in the hippocampus from the NAPE-PLD
knock-out mouse (Figures 1B,C) and PPARα knock-out mouse
(Figures 1D,E) when compared with those of the respective wild-
type mice (see references in Table 1 for further information).
Calbindin D28k, calretinin, and parvalbumin antibodies were
evaluated for specificity and potency (see references in Table 1)
using several methods: (a) by indirect immunofluorescent or
immunoperoxidase labeling, as well as biotin-avidin labeling,
of 4% formaldehyde fixed brains; (b) by immunoenzymatic
labeling of immunoblots; (c) by radioimmunoassay; or (d) by
immunohistochemistry of the brain tissue of calbindin knock-out
mice, calretinin knock-out mice or parvalbumin knock-out mice,
respectively.
RESULTS
In the present study, we first analyzed the distribution and the co-
expression of PPARα and NAPE-PLD with the CaBPs calbindin,
calretinin, and parvalbumin in the rat hippocampus. The inten-
sity of the immunoreactivity for each antibody was similar in all
brains analyzed in the present study. The results for this study
are described in the text and are summarized using a rating scale
(Table 3). The gray-scale values measured in the hippocampus
are represented using an arbitrary scale of three labeling intensi-
ties, from “+” meaning “low” (above the background density) to
“+ + +” meaning “high” (according to the highest signal density
in the specimen). Previously, we performed Western blot analysis
to ensure that the PPARα, NAPE-PLD, calbindin, calretinin, and
parvalbumin antibodies recognized the corresponding antigens in
the rat hippocampus (Figure 1A). Thus, Western blot analyses of
the protein extracts from the rat hippocampus revealed PPARα
immunostaining as a prominent band at approximately 52 kDa.
Immunoblots for NAPE-PLD also revealed a single band with a
molecular mass of 46 kDa. Analysis of calbindin D28k, calretinin
and parvalbumin confirmed the expected bands of 28, 29, and
10 kDa, respectively (Figure 1A).
DISTRIBUTION OF PPARα, NAPE-PLD, AND CaBPs IN THE ADULT RAT
HIPPOCAMPUS
To address the cell distribution of PPARα, NAPE-PLD and the
CaBPs calbindin D28k, calretinin and parvalbumin in the rat hip-
pocampus, coronal sections of the hippocampus were subjected
to immunohistochemical analysis (Figure 2). Along the hip-
pocampal complex, an intense and specific nuclear immunore-
activity for PPARα was detected in most cells localized in the
granular cell layer (gcl) of the DG and stratum pyramidale (SP) of
the CA1/3 fields (Figures 2A–F). Nuclear PPARα labeling was also
observed in a number of non-principal cells widely distributed in
the remaining layers and strata of the hippocampus, such as the
molecular layer (ml) of the DG and the strata oriens (SO), radia-
tum (SR) and lacunosum-moleculare (SL-M) of the CA fields.
Interestingly, it should be noted that some hippocampal cells in
the SP showed additional staining for PPARα in their cytoplasm
(Figure 2F).
NAPE-PLD immunoreactivity was specifically associated with
neuropil and puncta in the ml and gcl of the DG, and the SO
and SP of the CA1/3 fields (Figures 2G–I). In the SP of CA3,
this neuropil surrounded the unstained profiles of the pyrami-
dal cells. Weaker staining for NAPE-PLD was observed in puncta
localized in the remaining hippocampal layers, and noteworthy
staining was found in the basal part of the CA3 stratum radiatum,
probably stratum lucidum (Figure 2I). Interestingly, a number of
NAPE-PLD+ cells were observed in the dentate granular (gcl) and
polymorphic (pcl or hilus) cell layers and the SP of the CA1/3
Table 3 | Immunoreactivity in the rat hippocampusa.
PPARα NAPE-PLD Calbindin Calretinin Parvalbumin
Nuclei Somata Fibers Somata Fibers Somata Fibers Somata Fibers
DG ml + − + + + + + − + − −
gcl + + + + − + + + + + + − − + + + +
pcl + ++ − + + + + − −
CA3 SO + + + − − − + − +
SP + + + ++ + − − + + ++ + + +
SR + − −/+ (SL) + −/ + ++ (SL) + + − +
CA1 SO + − + + − − − + −
SP + + + + + + − + − + ++
SR + + − + − + − − −
SL-M + + + + + + − − −
aRating scale of the immunoreactivity in nuclei, somata and fibers of each layer and stratum of the hippocampus. Symbols are as follows: high (+ + +), medium
(++), low (++), and without immunoreactivity (−). Abbreviations: DG, dentate gyrus; gcl, granular cell layer; ml, molecular layer; pcl, polymorphic cell layer (hilus);
SL, stratum lucidum; SL-M, stratum lacunosum-moleculare; SO, stratum oriens; SP, stratum pyramidale; SR, stratum radiatum.
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FIGURE 2 | Immunohistochemical expression of PPARα (A–F), NAPE-PLD
(G–L) and the CaBPs calbindin (M–O), calretinin (P–R) and parvalbumin
(S–U) in the medial rat hippocampus. (A–F) Arrows indicate PPARα
expression in the cell nuclei of the dentate granular, pyramidal, and
non-pyramidal (interneurons) cells. The arrowhead in (F) indicates the
cytoplasmic labeling of PPARα. (G–L) NAPE-PLD was associated with
neuropil and puncta in the ml and gcl of the DG and the SO and SP of the
CA1/3 fields. The arrows indicate the NAPE-PLD+ cells observed in the pcl of
the DG and the SP of the CA1/3 fields. (M–O) Fibers in the ml of the DG and
the SL of CA3 and cells in the gcl of the DG and the SO, SP, and SR of the
CA1/3 fields were stained for calbindin. (P–R) A discrete number of cells in
the pcl of the DG and all strata of the CA1/3 fields expressed calretinin. (S–U)
Cells stained for parvalbumin were found in the gcl of the DG and the SP and
SO of the CA1/3 fields, whereas fibers were observed in the gcl of the DG
and the SP of the CA1/3 fields. For abbreviations, see Table 3 legend. Scale
bars are indicated in each image.
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fields (Figures 2J–L). The remaining hippocampal layers showed
a very small number of immunostained cells.
A large number of cells immunoreactive for calbindin D28k
were detected in the gcl of the DG (Figure 2M). These calbindin+
cells showed moderate staining in comparison with the intense
immunoreactivity observed in a few cells localized in the SO,
SP, and SR of the CA1/3 fields (Figures 2M–O, insets). There
appeared to be a slightly higher number of calbindin stained cells
in the more temporal aspect of CA1. A high density of fibers was
intensely stained for calbindin in the ml of the DG and the SL of
CA3 (Figures 2M,O). Weaker calbindin staining was observed in
the fibers of the pcl of the DG and in a band situated in the limit
between the SR and SL-M of CA1 (Figures 2M,N).
Intense immunoreactivity for calretinin was associated with
the somata and the proximal projections in a discrete number of
cells localized in the pcl of the DG and all strata of the CA1/3
fields (Figures 2P–R, insets). A weak network of calretinin+ fibers
was detected in the border between the gcl and ml of the DG
(Figure 2P).
A discrete number of intensely stained cells positive for parval-
bumin, which comprised the somata and proximal projections,
was observed in the gcl of DG and the SP and SO of the CA1/3
fields (Figures 2S–U). Parvalbumin immunoreactivity was also
associated with a dense meshwork of fibers localized in the gcl of
the DG and the SP of the CA1/3 fields. These fibers surrounded
the unstained profiles of the principal cells (Figures 2S–U, insets).
CO-LOCALIZATION OF PPARα AND CaBPs IN THE ADULT RAT
HIPPOCAMPUS
To study the co-expression of PPARα and the CaBPs calbindin
D28k, calretinin and parvalbumin in the hippocampus, coronal
sections were subjected to double-immunolabeling and confo-
cal microscope analysis. DAPI immunofluorescence was used to
determine the subcellular localization of PPARα and the CaBPs.
PPARα and calbindin were highly co-expressed in most cell bod-
ies of the gcl and ml of the DG (Figures 3A–E). Thus, the
immunofluorescent signal of most PPARα+ cells (red) was local-
ized in their cell nuclei, whereas the immunofluorescent signal
of the calbindin+ cells (green) was mainly found in their cyto-
plasm (Figures 3D,E). In contrast, the PPARα+ cells in the pcl of
the DG did not co-express calbindin, but they were surrounded
by calbindin+ fibers (Figure 3F). Co-existence of PPARα and cal-
bindin was observed in a small number of cells of the SP of
CA1 but was not observed in the SP of CA3 (Figures 3G–L).
Co-expression of PPARα and calbindin was scarce in the cells
of the remaining strata in the CA1/3 fields (Figures 3M–Q).
Interestingly, the intense network of calbindin+ fibers observed
in the SL of CA3 was closely arranged around cells exhibiting
PPARα immunofluorescence in the cell nucleus and cytoplasm
(Figure 3R).
Regarding calretinin and parvalbumin expression, co-
expression in PPARα+ cells was scarce in the rat hippocampus
(Figures 4, 5). PPARα and calretinin were co-expressed in some
cells of the pcl of the DG (Figures 4A–F), the SO, SP, and SR of
CA1 (Figures 4G–L) and the SO and SP of CA3 (Figures 4M–R).
PPARα+/parvalbumin+ cells were mainly localized in the inner
border of the gcl of the DG (Figures 5A–F, insets), the SP of CA1
(Figures 5G–L, insets) and the SP and SR of CA3 (Figures 5M–R,
insets). In all cases, similar to calbindin, both calretinin and par-
valbumin were localized in the cytoplasm (Figures 5D,K,Q,R).
The meshwork of parvalbumin+ fibers localized in the gcl of the
DG and the SP of the CA1/3 fields surrounded the PPARα+ cells
(Figures 5D,J,P).
CO-LOCALIZATION OF NAPE-PLD AND CaBPs IN THE ADULT RAT
HIPPOCAMPUS
To study the co-existence of NAPE-PLD and the CaBPs calbindin
D28k, calretinin and parvalbumin in the hippocampus, coronal
sections were also subjected to double-immunolabeling and con-
focal microscope analysis. The high number of calbindin+ cells
localized in the gcl of the DG was surrounded by a meshwork of
NAPE-PLD+ neuropil and puncta (Figures 6A–E). We could also
find co-expression of NAPE-PLD and calbindin in some cells of
the gcl of the DG (Figure 6F). In the SP of CA1, NAPE-PLD+
neuropil and puncta also surrounded some calbindin+ cells and a
number of unstained profiles of pyramidal cells (Figures 6G–L).
In contrast, we could not find NAPE-PLD+ puncta surround-
ing calbindin+ cells in the SP of CA3 (Figures 6M–P), but we
observed NAPE-PLD labeling in the somata of the calbindin+
cells in the SR of CA3 (Figures 6Q,R).
We also observed NAPE-PLD labeling in the somata and
proximal axons of the calretinin+ cells localized in the gcl of
the DG (Figures 7A–E) and the SP and SR of the CA1/3 fields
(Figures 7G–J,M–R). NAPE-PLD+ puncta were detected on the
surface of some somata, as well as in the proximal axons, of cells in
the gcl of the DG (Figure 7F) and the SP of CA1 (Figures 7K,L).
Most NAPE-PLD+ cells localized in the gcl and pcl of the DG
and the SP of the CA1/3 fields also exhibited parvalbumin expres-
sion (Figures 8A–E,G–R). Some NAPE-PLD+/parvalbumin−
cells in the gcl of the DG were surrounded by parvalbumin+
puncta (Figure 8F). Moreover, the unstained profiles of granu-
lar cells in the DG and the pyramidal cells in the CA fields were
surrounded by parvalbumin+ fibers and puncta that were closely
intercalated with NAPE-PLD+ puncta (Figures 8D,J,P).
QUANTIFICATION OF CO-LOCALIZATION IN THE ADULT RAT
HIPPOCAMPUS
We quantified the proportion of PPARα or NAPE-PLD-labeled
cells that express calbindin, calretinin or parvalbumin in each
layer of the DG, CA3, and CA1 (Figure 9). All PPARα-labeled cells
express calbindin in the granular cell layer of the DG. A lower
proportion of PPARα-calbindin-labeled cells was also found in
the molecular (32.2%) and polymorphic (7.9%) cell layers of
the DG (Figure 9A), SR of CA3 (15.4%) (Figure 9B), and SO
(30.5%), SP (18.4%), SR (39.6%), and SL-M (29.65) of CA1
(Figure 9C). We observed a low percentage of cells that express
PPARα and calretinin in the polymorphic cell layer of the DG
(3.7%) (Figure 9A), and SO (10.5%), SP (2.3%), and SR (11.2%)
of CA1 (Figure 9C). We also observed a very low percentage of
cells that express PPARα and parvalbumin in the subgranular
zone (sgz) of the DG (5.1%) (Figure 9A), SP (4.3%) and SR
(7.1%) of CA3 (Figure 9B), and SO (6.3%) and SP (3.9%) of
CA1 (Figure 9C). A proportion of NAPE-PLD-calbindin-labeled
cells was obtained in the sgz of the DG (20.5%) (Figure 9D), and
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FIGURE 3 | PPARα and calbindin co-expression in the rat hippocampus.
Low-resolution epifluorescence photomicrographs (A–C,G–I,M–O) and
high-resolution confocal laser scanning photomicrographs (D–F,J–L,P–R)
showing the immunoreactivity of calbindin (green) and PPARα (red) in the
dentate gyrus (DG), CA1, and CA3 areas. DAPI fluorescence (blue) was used
to identify the cell nuclei of specific hippocampal cell populations. The arrows
indicate PPARα expression in the cell nucleus. The arrowheads indicate the
cytoplasmic labeling of PPARα or calbindin. The asterisks indicate examples
of cells that co-express PPARα and calbindin. For abbreviations, see Table 3
legend. Scale bars are indicated in each image.
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FIGURE 4 | PPARα and calretinin co-expression in the rat
hippocampus. Low-resolution epifluorescence photomicrographs
(A–C,G–I,M–O) and high-resolution confocal laser scanning
photomicrographs (D–F,J–L,P–R) showing the labeling of calretinin (green)
and PPARα (red) in the dentate gyrus (DG), CA1, and CA3 areas. DAPI
fluorescence (blue) is also shown. The arrows indicate PPARα expression
in the cell nucleus. The arrowheads indicate the cytoplasmic labeling of
calretinin. The asterisks indicate examples of cells that co-express PPARα
and calretinin. For abbreviations, see Table 3 legend. Scale bars are
indicated in each image.
Frontiers in Neuroanatomy www.frontiersin.org March 2014 | Volume 8 | Article 12 | 9
Rivera et al. PPARα and Ca2+-binding proteins in the hippocampus
FIGURE 5 | PPARα and parvalbumin co-expression in the rat
hippocampus. Low-resolution epifluorescence photomicrographs
(A–C,G–I,M–O) and high-resolution confocal laser scanning
photomicrographs (D–F,J–L,P–R) showing the labeling of parvalbumin
(green) and PPARα (red) in the dentate gyrus (DG), CA1, and CA3
areas. DAPI fluorescence (blue) is also shown. The arrows indicate
PPARα expression in the cell nucleus. The asterisks indicate
examples of cells that co-express PPARα and parvalbumin. For
abbreviations, see Table 3 legend. Scale bars are indicated in each
image.
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FIGURE 6 | NAPE-PLD and calbindin co-expression in the rat
hippocampus. Low-resolution epifluorescence photomicrographs
(A–C,G–I,M–O) and high-resolution confocal laser scanning
photomicrographs (D–F,J–L,P–R) showing the labeling of calbindin
(green) and NAPE-PLD (red) in the dentate gyrus (DG), CA1,
and CA3 areas. The arrows indicate NAPE-PLD expression in the
calbindin+ cells. The arrowheads indicate the NAPE-PLD+ fiber
varicosities on the surface of the calbindin+ cells. For
abbreviations, see Table 3 legend. Scale bars are indicated in
each image.
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FIGURE 7 | NAPE-PLD and calretinin co-expression in the rat
hippocampus. Low-resolution epifluorescence photomicrographs
(A–C,G–I,M–O) and high-resolution confocal laser scanning
photomicrographs (D–F,J–L,P–R) showing the labeling of calretinin
(green) and NAPE-PLD (red) in the dentate gyrus (DG), CA1,
and CA3 areas. The arrows indicate NAPE-PLD expression in the
calretinin+ cells. The arrowheads indicate the NAPE-PLD+ fiber
varicosities on the surface of the calretinin+ cells. For
abbreviations, see Table 3 legend. Scale bars are indicated in
each image.
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FIGURE 8 | NAPE-PLD and parvalbumin co-expression in the rat
hippocampus. Low-resolution epifluorescence photomicrographs
(A–C,G–I,M–O) and high-resolution confocal laser scanning
photomicrographs (D–F,J–L,P–R) showing the labeling of parvalbumin
(green) and NAPE-PLD (red) in the dentate gyrus (DG), CA1, and CA3
areas. The arrows indicate NAPE-PLD expression in the parvalbumin+
cells. For abbreviations, see Table 3 legend. Scale bars are indicated in
each image.
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FIGURE 9 | Quantification of the proportion of cells labeled with PPARα (A–C) or NAPE-PLD (D–F) that express calbindin, calretinin, or parvalbumin in
each layer of the dentate gyrus, CA3, and CA1. Bars represent the percentage of labeled cells in each layer.
SR of CA3 (7.2%) (Figure 9E). We also observed a representative
percentage of NAPE-PLD-labeled cells that express parvalbumin
in the granular (21.1%) and polymorphic (16.9%) cell layers
of the DG (Figure 9D). Finally, a percentage of NAPE-PLD-
labeled cells expressing parvalbumin or calretinin was observed
in SO (11.6 and 10.7%, respectively), SP (20.3 and 32.9%, respec-
tively) and SR (20.1%) of CA3 (Figure 9E), and SO (15.4 and
12.8%, respectively) and (11.3 and 18.8%, respectively) SP of CA1
(Figure 9F).
DISCUSSION
The biological activities of monounsaturated NAEs require both
release from membrane precursors by the Ca2+-dependent
NAPE-PLD and the activation of PPARα receptors that mod-
ulate Ca2+-dependent mechanisms. Thus, the identification of
specific populations of NAPE-PLD/PPARα-containing neurons
that express selective Ca2+-binding proteins (CaBPs)may provide
a neuroanatomical basis to better understand the NAEs/PPARα
signaling system in the brain. Our study provides evidence for
an anatomical segregation of the PPARα signaling system in hip-
pocampal cells by identifying the localization and co-existence of
PPARα, NAPE-PLD, and the CaBPs calbindin, calretinin and par-
valbumin, which have not been previously described. Due to the
specific localization of PPARα in the cell nuclei, NAPE-PLD in
particular puncta and cells, and CaBPs in certain cell bodies and
fibers, we were able to highlight at least 4 different cell popula-
tions in the rat hippocampus (Figure 10). First, we observed that
most dentate granular cells and some CA1 pyramidal cells co-
expressed both calbindin and nuclear PPARα. These calbindin+
cells containing PPARα were closely surrounded by NAPE-PLD+
fiber varicosities (Figure 10A). Cells expressing both calbindin
and PPARα were also found in the SR of CA1/3 (Figure 10B).
Second, we observed that most cells containing parvalbumin
expressed both NAPE-PLD and PPARα in the principal cell layers
of the DG and CA1/3 fields (Figure 10C). Cells expressing both
parvalbumin and NAPE-PLD were also found in the pcl of the
DG (Figure 10D). Third, cell bodies that expressed calretinin, but
most likely not PPARα, were also surrounded by NAPE-PLD+
puncta in the principal cell layers of the DG and CA1/3 fields
(Figure 10C). Fourth, a small number of PPARα+ cell bodies
expressed calretinin, mainly in the non-principal cell layers of the
hippocampus (Figure 9E).
We observed that NAPE-PLD immunostaining was completely
absent in the NAPE-PLD knock-out mouse hippocampus (Leung
et al., 2006; Nyilas et al., 2008), whereas the wild type mouse
showed similar labeling to that described by Egertová et al.
(2008). Thus, in the mouse hippocampus, very intense NAPE-
PLD immunoreactivity was localized in the mossy fibers of the
polymorphic cell layer of the DG and the stratum lucidum of
CA3. Weaker staining was also observed in the molecular layer
of the DG and the strata oriens and radiatum of the CA fields.
In contrast to Egertová et al. (2008), we observed a number of
NAPE-PLD+ cells in the granular and polymorphic cell layers
of the DG and the stratum pyramidale of the CA fields in the
Frontiers in Neuroanatomy www.frontiersin.org March 2014 | Volume 8 | Article 12 | 14
Rivera et al. PPARα and Ca2+-binding proteins in the hippocampus
FIGURE 10 | Schematic representation of the main cell populations
containing PPARα/NAPE-PLD that expressed the CaBPs calbindin,
calretinin, and parvalbumin in the different hippocampal regions.
(A) Most dentate granular cells and some CA1 pyramidal cells
co-expressed calbindin and nuclear PPARα and were closely surrounded by
NAPE-PLD+ fiber varicosities. (B) Cells expressing both calbindin and
PPARα were also found in the SR of CA1/3. (C) In the principal cell layers of
the DG and the CA1/3 fields, most cells containing parvalbumin expressed
both NAPE-PLD and PPARα, and the cell bodies that expressed calretinin,
but most likely not PPARα, were surrounded by NAPE-PLD+ puncta.
(D) Cells expressing both parvalbumin and NAPE-PLD were also found in
the pcl of the DG. (E) A small number of PPARα+ cell bodies expressed
calretinin, mainly in the non-principal cell layers of the hippocampus.
mouse hippocampus, as well as in the rat hippocampus. No
stained cells were detected in the hippocampus of the NAPE-PLD
knock-out mouse. Additionally, some differences in NAPE-PLD
immunostaining were foundwhen the rat andmouse hippocampi
were compared. Thus, it should be noted a weaker NAPE-PLD
immunoreactivity in the basal part of the CA3 stratum radiatum
in the rat hippocampus. On the contrary, a high density of NAPE-
PLD+ neuropil and puncta were observed in the stratum pyra-
midale of the CA fields, but not in the dentate polymorphic cell
layer. These fibers surrounded the unstained cells, similar to those
described in the polymorphic cell layer of the mouse hippocam-
pus (Egertová et al., 2008). These results suggest specie-specific
differences, at least at protein level of NAPE-PLD, between the rat
and mouse hippocampi.
Our results confirm data from previous studies on the presence
and localization of PPARα in the rat hippocampus (Cullingford
et al., 1998; Moreno et al., 2004). However, Moreno and collab-
orators showed PPARα immunoreactivity in both nuclear and
cytoplasmic localizations, whereas we observed PPARα expres-
sion specifically in the cell nucleus and, occasionally, in the
cytoplasm of scattered cells. Calbindin immunoreactivity was
described in the granular cells of the DG, some pyramidal cells
of CA1 and scattered interneurons of the SR of hippocampus
(Baimbridge and Miller, 1982). In the present study, we observed
that calbindin+ cells expressed nuclear PPARα in the principal
cell layers of the DG and CA1 and in the stratum radiatum
of CA1/3. The presence of PPARα+/calbindin+ cells in specific
localizations of the hippocampus provides neuroanatomical evi-
dence of the relationship between the neuroprotective role of
PPARα in neurodegenerative disorders (Aleshin et al., 2013) and
the dysregulation of neuronal calcium homeostasis, such as in
calbindin-deficient mice, which have impaired long-term hip-
pocampal potentiation and thus impaired spatial learning and
memory functioning (Molinari et al., 1996; Hajieva et al., 2009;
Soontornniyomkij et al., 2012). For instance, the over-expression
of calbindin selectively in the dentate granule cells disrupted
the presynaptic function of the mossy fibers, reduced long-term
potentiation and impaired spatial memory (Dumas et al., 2004).
It is interestingly to note that no PPARα+/calbindin+ cells were
detected in the stratum pyramidale of CA3, and the pyramidal
cells of CA3, which did not contain PPARαand calbindin, are one
of the cell types that are most susceptible to burst discharge and
epileptiform activity (Kandel and Spencer, 1961).
Parvalbumin+ cells were specifically localized in the granu-
lar and polymorphic cell layers of the DG and the strata oriens
and pyramidale in the CA1/3 fields of the rat hippocampus
(Kosaka et al., 1987). These cells have been considered a sub-
population of GABAergic interneurons, including the basket
and axo-axonic cell types. In the present study, we described
PPARα+/parvalbumin+ cells and NAPE-PLD+/parvalbumin+
cells that were specifically concentrated in the granular cell
layer of the DG and the stratum pyramidale of the CA1/3
fields. Based on their morphology and localization in the hip-
pocampal layers, it is reasonable to suggest that PPARα and
NAPE-PLD are expressed in the same parvalbumin cell pop-
ulation (i.e., basket cells). Moreover, based on the physiolog-
ical characteristics of the neurons with parvalbumin content
(Heizmann, 1984) and their important role in the synchroniza-
tion of action potential discharges (Freund, 2003), we hypothesize
that the PPARα/NAPE-PLD/parvalbumin-containing GABAergic
neurons may be characterized by their high spontaneous dis-
charge rate and high firing rate in response to depolarizing
currents, at least in the hippocampus (Schwartzkroin and Kunkel,
1985; Celio, 1986; Kosaka et al., 1987). Thus, it is conceivable
to think that impairment of endocannabinoid tone in the hip-
pocampal basket cells is likely to result in alteration in cognitive
processes and mood disorders such as anxiety (Busquets-Garcia
et al., 2011). The presence of PPARα+/parvalbumin+ cells in
specific localizations of the hippocampus can provide other neu-
roanatomical evidence regarding the relationship between the
neuroprotective role of PPARα in the prevention of calcium influx
induced by H2O2 and the enhancement of calcium resequestra-
tion by parvalbumin and its implications in energy metabolism
(Santos et al., 2005; Seebacher and Walter, 2012).
Previous observations in the rat hippocampus indicated that
calretinin-containing neurons were heterogeneous both morpho-
logically and neurochemically (Gulyás et al., 1992; Miettinen
et al., 1992). Calretinin immunoreactivity was almost exclusively
described in GABAergic non-pyramidal cells in the layers of the
DG and the CA1/3 fields, being most abundant in the poly-
morphic cell layer of the DG and the stratum lucidum of CA3.
However, GABA-negative calretinin-containing neurons that are
Frontiers in Neuroanatomy www.frontiersin.org March 2014 | Volume 8 | Article 12 | 15
Rivera et al. PPARα and Ca2+-binding proteins in the hippocampus
specifically localized in the polymorphic cell layer of the DG
and the stratum lucidum of CA3 have been described (Miettinen
et al., 1992). In the present study, we observed that very few
calretinin+ cells expressed PPARα in the hippocampus; most of
the calretinin+ cells were in the polymorphic cell layer of the DG
and the stratum oriens of CA3. Thus, further analysis is necessary
to determine whether PPARα+/calretinin+ cells are GABAergic
neurons, at least in the polymorphic cell layer of the DG.
In conclusion, our data indicated the presence of hippocam-
pal cell subpopulations with specific co-expression patterns of the
NAPE-PLD/PPARα system and selective CaBPs. As the CaBPs cal-
bindin, calretinin and parvalbumin are found in a limited number
of hippocampal cell types that express PPARα and NAPE-PLD,
we suggest that these CaBPs-expressing cells, especially those
expressing calbindin and parvalbumin, may be involved in more
specialized Ca2+-regulated functions related to the biological
roles of the PPARα signaling system.
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